Differential/JJ
RNA/NN
display/NN
identifies/VBZ
novel/JJ
genes/NNS
associated/VBN
with/IN
decreased/VBN
vitamin/NN
D/NN
receptor/NN
expression/NN
./.

To/TO
characterize/VB
further/RB
the/DT
function/NN
of/IN
the/DT
intracellular/JJ
vitamin/NN
D/NN
receptor/NN
(/(
VDR/NN
)/)
,/,
we/PRP
have/VBP
developed/VBN
stable/JJ
transfectant/JJ
variants/NNS
of/IN
a/DT
vitamin/NN
D-responsive/JJ
cell/NN
line/NN
(/(
U937/NN
)/)
which/WDT
express/VBP
either/CC
decreased/VBN
or/CC
increased/VBN
numbers/NNS
of/IN
VDR/NN
./.
=====
In/IN
this/DT
study/NN
we/PRP
have/VBP
analyzed/VBN
changes/NNS
in/IN
gene/NN
expression/NN
associated/VBN
with/IN
this/DT
variable/JJ
VDR/NN
expression/NN
./.
=====
Initial/JJ
experiments/NNS
indicated/VBD
that/IN
a/DT
50/CD
%/NN
decrease/NN
in/IN
VDR/NN
levels/NNS
was/VBD
associated/VBN
with/IN
a/DT
2-fold/JJ
increase/NN
in/IN
cell/NN
proliferation/NN
and/CC
a/DT
similar/JJ
rise/NN
in/IN
c-myc/NN
mRNA/NN
expression/NN
./.
=====
Further/JJ
studies/NNS
were/VBD
carried/VBN
out/RP
using/VBG
differential/JJ
RNA/NN
display/NN
(/(
DD/NN
)/)
./.
=====
Sequence/NN
analysis/NN
of/IN
DD/NN
products/NNS
revealed/VBD
two/CD
cDNAs/NNS
with/IN
identity/NN
to/TO
known/VBN
gene/NN
products/NNS
:/:
the/DT
catalytic/JJ
sub-unit/NN
of/IN
DNA-protein/JJ
kinase/NN
(/(
DNA-PK(CS)/NN
)/)
,/,
and/CC
the/DT
peroxisomal/JJ
enzyme/NN
17beta-hydroxysteroid/NN
dehydrogenase/NN
type/NN
IV/CD
(/(
17beta-HSD/NN
IV/CD
)/)
./.
=====
Northern/NN
analysis/NN
confirmed/VBD
that/IN
expression/NN
of/IN
both/DT
mRNAs/NNS
was/VBD
reduced/VBN
in/IN
cells/NNS
with/IN
decreased/VBN
numbers/NNS
of/IN
VDR/NN
./.
=====
Down-regulation/NN
of/IN
17beta-HSD/NN
IV/CD
mRNA/NN
expression/NN
was/VBD
associated/VBN
with/IN
enhanced/VBN
estradiol/NN
inactivation/NN
by/IN
U937/NN
cells/NNS
,/,
suggesting/VBG
a/DT
link/NN
between/IN
estrogenic/JJ
pathways/NNS
and/CC
cell/NN
proliferation/NN
./.
=====
Further/JJ
Northern/NN
analyses/NNS
indicated/VBD
that/IN
there/EX
was/VBD
no/DT
significant/JJ
change/NN
in/IN
17beta-HSD/NN
IV/CD
or/CC
DNA-PK(CS)/NN
mRNA/NN
levels/NNS
following/VBG
treatment/NN
with/IN
1,25(OH)2D3/NN
,/,
although/IN
expression/NN
of/IN
both/DT
genes/NNS
varied/VBD
with/IN
changes/NNS
in/IN
cell/NN
proliferation/NN
./.
=====
These/DT
data/NNS
suggest/VBP
that/IN
,/,
in/IN
addition/NN
to/TO
its/PRP$
established/JJ
role/NN
as/IN
a/DT
hormone-dependent/JJ
trans-activator/NN
,/,
VDR/NN
may/MD
influence/VB
gene/NN
expression/NN
by/IN
ligand-independent/JJ
mechanisms/NNS
./.